Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S – Biotech Investments
CS MEDICA / Key word(s): IPO CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S 10-Jun-2024 / 14:06 CET/CEST Disclosure of an inside
June 11, 2024